2026 Global: Abdominal Aortic Aneurysm (Aaa) Repair Devices-Competitive Review (2032) report
Description
The 2026 Global: Abdominal Aortic Aneurysm (Aaa) Repair Devices-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for abdominal aortic aneurysm (aaa) repair devices by geography and historical trend. The scope of the report extends to sizing of the abdominal aortic aneurysm (aaa) repair devices market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The abdominal aortic aneurysm (AAA) repair devices market is dominated by ten major companies: Medtronic, Cook Medical (Cook Group), W. L. Gore & Associates (Gore Medical), Terumo Corporation, Endologix LLC, MicroPort Scientific Corporation, Artivion Inc., Lombard Medical, Cardinal Health, and Lifetech Scientific. These firms lead in developing endovascular aneurysm repair (EVAR) systems, including stent grafts and fenestrated designs, addressing the growing demand for minimally invasive treatments amid rising AAA prevalence linked to aging populations. Medtronic pioneers comprehensive EVAR platforms like the Endurant stent graft, emphasizing durability and broad anatomical applicability, while Cook Medical excels in customized fenestrated and branched grafts for complex juxta-renal aneurysms. W. L. Gore & Associates advances biocompatible materials in devices such as the Excluder, reducing endoleak risks through superior conformability.
Terumo Corporation contributes radial access innovations and reliable stent grafts, enhancing procedural safety and usability in high-volume centers, complemented by Endologix LLC's AFX and Nellix systems tailored for challenging neck anatomies via anatomical fixation. MicroPort Scientific offers cost-effective, clinically validated options like Firehawk-integrated grafts, gaining traction in emerging markets, while Artivion Inc. (formerly Jotec) specializes in multi-branch systems for thoracoabdominal extensions. Lombard Medical's Altura and fenestrated FEVAR grafts target precise infrarenal deployments, and Cardinal Health supports distribution alongside innovative delivery sheaths. Lifetech Scientific's Abdominal Aortic Aneurysm Stent Graft System bolsters the pipeline with affordable, high-performance alternatives.
Market concentration among these leaders drives innovation, with projected growth from $2.28 billion in 2020 to $3.86 billion by 2030, fueled by R&D in next-generation platforms like ChEVAS (Endologix) and Nectero EAST. Competitive strategies include mergers, such as Endologix's integrations, and global expansions by Terumo and MicroPort to counter challenges like tortuous anatomies and regulatory hurdles. These companies collectively hold substantial shares through superior engineering, clinical trial leadership, and physician training, ensuring sustained dominance in synthetic graft and EVAR segments.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for abdominal aortic aneurysm (aaa) repair devices by geography and historical trend. The scope of the report extends to sizing of the abdominal aortic aneurysm (aaa) repair devices market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The abdominal aortic aneurysm (AAA) repair devices market is dominated by ten major companies: Medtronic, Cook Medical (Cook Group), W. L. Gore & Associates (Gore Medical), Terumo Corporation, Endologix LLC, MicroPort Scientific Corporation, Artivion Inc., Lombard Medical, Cardinal Health, and Lifetech Scientific. These firms lead in developing endovascular aneurysm repair (EVAR) systems, including stent grafts and fenestrated designs, addressing the growing demand for minimally invasive treatments amid rising AAA prevalence linked to aging populations. Medtronic pioneers comprehensive EVAR platforms like the Endurant stent graft, emphasizing durability and broad anatomical applicability, while Cook Medical excels in customized fenestrated and branched grafts for complex juxta-renal aneurysms. W. L. Gore & Associates advances biocompatible materials in devices such as the Excluder, reducing endoleak risks through superior conformability.
Terumo Corporation contributes radial access innovations and reliable stent grafts, enhancing procedural safety and usability in high-volume centers, complemented by Endologix LLC's AFX and Nellix systems tailored for challenging neck anatomies via anatomical fixation. MicroPort Scientific offers cost-effective, clinically validated options like Firehawk-integrated grafts, gaining traction in emerging markets, while Artivion Inc. (formerly Jotec) specializes in multi-branch systems for thoracoabdominal extensions. Lombard Medical's Altura and fenestrated FEVAR grafts target precise infrarenal deployments, and Cardinal Health supports distribution alongside innovative delivery sheaths. Lifetech Scientific's Abdominal Aortic Aneurysm Stent Graft System bolsters the pipeline with affordable, high-performance alternatives.
Market concentration among these leaders drives innovation, with projected growth from $2.28 billion in 2020 to $3.86 billion by 2030, fueled by R&D in next-generation platforms like ChEVAS (Endologix) and Nectero EAST. Competitive strategies include mergers, such as Endologix's integrations, and global expansions by Terumo and MicroPort to counter challenges like tortuous anatomies and regulatory hurdles. These companies collectively hold substantial shares through superior engineering, clinical trial leadership, and physician training, ensuring sustained dominance in synthetic graft and EVAR segments.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.